Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 256

1.

Determinants of sinus rhythm maintenance in patients with early-persistent atrial fibrillation and heart failure.

de With RR, Rienstra M, Crijns HJGM, Van Gelder IC; RACE 3 investigators.

Clin Res Cardiol. 2019 Nov 29. doi: 10.1007/s00392-019-01581-0. [Epub ahead of print] No abstract available.

PMID:
31784901
2.

Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.

Schnabel RB, Haeusler KG, Healey JS, Freedman B, Boriani G, Brachmann J, Brandes A, Bustamante A, Casadei B, Crijns HJGM, Doehner W, Engström G, Fauchier L, Friberg L, Gladstone DJ, Glotzer TV, Goto S, Hankey GJ, Harbison JA, Hobbs FDR, Johnson LSB, Kamel H, Kirchhof P, Korompoki E, Krieger DW, Lip GYH, Løchen ML, Mairesse GH, Montaner J, Neubeck L, Ntaios G, Piccini JP, Potpara TS, Quinn TJ, Reiffel JA, Ribeiro ALP, Rienstra M, Rosenqvist M, Sakis T, Sinner MF, Svendsen JH, Van Gelder IC, Wachter R, Wijeratne T, Yan B.

Circulation. 2019 Nov 26;140(22):1834-1850. doi: 10.1161/CIRCULATIONAHA.119.040267. Epub 2019 Nov 25.

PMID:
31765261
3.

Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring.

Linz D, Baumert M, Desteghe L, Kadhim K, Vernooy K, Kalman JM, Dobrev D, Arzt M, Sastry M, Crijns HJGM, Schotten U, Cowie MR, McEvoy RD, Heidbuchel H, Hendriks J, Sanders P, Lau DH.

Int J Cardiol Heart Vasc. 2019 Oct 18;24:100424. doi: 10.1016/j.ijcha.2019.100424. eCollection 2019 Sep. Review.

4.

How to make catheter ablation available world-wide?

Lankveld TAR, Vernooy K, Crijns HJGM, Linz D.

Int J Cardiol Heart Vasc. 2019 Aug 16;24:100411. doi: 10.1016/j.ijcha.2019.100411. eCollection 2019 Sep. No abstract available.

5.

Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study.

Kloosterman M, Crijns HJGM, Mulder BA, Groenveld HF, Van Veldhuisen DJ, Rienstra M, Van Gelder IC.

Europace. 2019 Nov 20. pii: euz300. doi: 10.1093/europace/euz300. [Epub ahead of print]

PMID:
31747018
6.

Initial Imaging-Guided Strategy Versus Routine Care in Patients With Non-ST-Segment Elevation Myocardial Infarction.

Smulders MW, Kietselaer BLJH, Wildberger JE, Dagnelie PC, Brunner-La Rocca HP, Mingels AMA, van Cauteren YJM, Theunissen RALJ, Post MJ, Schalla S, van Kuijk SMJ, Das M, Kim RJ, Crijns HJGM, Bekkers SCAM.

J Am Coll Cardiol. 2019 Nov 19;74(20):2466-2477. doi: 10.1016/j.jacc.2019.09.027.

PMID:
31727284
7.

Nurse-led vs. usual-care for atrial fibrillation.

Wijtvliet EPJP, Tieleman RG, van Gelder IC, Pluymaekers NAHA, Rienstra M, Folkeringa RJ, Bronzwaer P, Elvan A, Elders J, Tukkie R, Luermans JGLM, Van Asselt ADIT, Van Kuijk SMJ, Tijssen JG, Crijns HJGM.

Eur Heart J. 2019 Sep 23. pii: ehz666. doi: 10.1093/eurheartj/ehz666. [Epub ahead of print]

PMID:
31544925
8.

Long-term outcomes of cryoballoon-based left atrial appendage isolation in addition to pulmonary vein isolation in persistent atrial fibrillation.

Yorgun H, Canpolat U, Okşul M, Şener YZ, Ateş AH, Crijns HJGM, Aytemir K.

Europace. 2019 Nov 1;21(11):1653-1662. doi: 10.1093/europace/euz232.

PMID:
31504432
9.

Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs.

Sutanto H, Laudy L, Clerx M, Dobrev D, Crijns HJGM, Heijman J.

Pharmacol Res. 2019 Oct;148:104444. doi: 10.1016/j.phrs.2019.104444. Epub 2019 Sep 4.

10.

Hypnotic communication during atrial fibrillation ablation: Another clinical application of hypnotherapy?

den Uijl DW, Crijns HJGM, Vernooy K, Linz D.

Int J Cardiol Heart Vasc. 2019 Aug 8;24:100408. doi: 10.1016/j.ijcha.2019.100408. eCollection 2019 Sep. No abstract available.

11.

Rising prevalence of atrial fibrillation in the elderly population: new challenges of geriatric cardiology.

Kloosterman M, Crijns HJGM, Van Gelder IC.

Europace. 2019 Oct 1;21(10):1451-1453. doi: 10.1093/europace/euz234. No abstract available.

PMID:
31424499
12.

Integrated specialized atrial fibrillation clinics reduce all-cause mortality: post hoc analysis of a randomized clinical trial.

Hendriks JML, Tieleman RG, Vrijhoef HJM, Wijtvliet P, Gallagher C, Prins MH, Sanders P, Crijns HJGM.

Europace. 2019 Aug 7. pii: euz209. doi: 10.1093/europace/euz209. [Epub ahead of print]

PMID:
31390464
13.

Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation. Reply.

Pluymaekers NAHA, Dudink EAMP, Crijns HJGM.

N Engl J Med. 2019 Jul 25;381(4):387-388. doi: 10.1056/NEJMc1906729. No abstract available.

PMID:
31340104
14.

Clinical assessment of aortic valve stenosis: Comparison between 4D flow MRI and transthoracic echocardiography.

Adriaans BP, Westenberg JJM, van Cauteren YJM, Gerretsen S, Elbaz MSM, Bekkers SCAM, Veenstra LF, Crijns HJGM, Wildberger JE, Schalla S.

J Magn Reson Imaging. 2019 Jun 30. doi: 10.1002/jmri.26847. [Epub ahead of print]

PMID:
31257647
15.

Vitamin K Antagonists, Non-Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation.

Peeters FECM, Dudink EAMP, Kimenai DM, Weijs B, Altintas S, Heckman LIB, Mihl C, Schurgers LJ, Wildberger JE, Meex SJR, Kietselaer BLJH, Crijns HJGM.

TH Open. 2018 Nov 10;2(4):e391-e398. doi: 10.1055/s-0038-1675578. eCollection 2018 Oct.

16.

Biological variation of cardiac markers in patients with aortic valve stenosis.

Peeters FECM, Kietselaer BLJH, Hilderink J, van der Linden N, Niens M, Crijns HJGM, Meex SJR.

Open Heart. 2019 May 8;6(1):e001040. doi: 10.1136/openhrt-2019-001040. eCollection 2019.

17.

Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset.

Chua W, Easter CL, Guasch E, Sitch A, Casadei B, Crijns HJGM, Haase D, Hatem S, Kääb S, Mont L, Schotten U, Sinner MF, Hemming K, Deeks JJ, Kirchhof P, Fabritz L.

BMC Cardiovasc Disord. 2019 May 21;19(1):120. doi: 10.1186/s12872-019-1105-4.

18.

Response to Letter From Vereckei Regarding, "QRS Area Is a Strong Determinant of Outcome in Cardiac Resynchronization Therapy".

van Stipdonk AMW, Ter Horst I, Kloosterman M, Engels EB, Rienstra M, Crijns HJGM, Vos MA, van Gelder IC, Prinzen FW, Meine M, Maass A, Vernooy K.

Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e007297. doi: 10.1161/CIRCEP.119.007297. No abstract available.

PMID:
30922071
19.

Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.

Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Jessurun GAJ, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, van de Ven PM, Oudemans-van Straaten HM, van Royen N.

N Engl J Med. 2019 Apr 11;380(15):1397-1407. doi: 10.1056/NEJMoa1816897. Epub 2019 Mar 18.

PMID:
30883057
20.

Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation.

Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, Meeder JG, Lenderink T, Widdershoven J, Bucx JJJ, Rienstra M, Kamp O, Van Opstal JM, Alings M, Oomen A, Kirchhof CJ, Van Dijk VF, Ramanna H, Liem A, Dekker LR, Essers BAB, Tijssen JGP, Van Gelder IC, Crijns HJGM; RACE 7 ACWAS Investigators.

N Engl J Med. 2019 Apr 18;380(16):1499-1508. doi: 10.1056/NEJMoa1900353. Epub 2019 Mar 18.

PMID:
30883054

Supplemental Content

Loading ...
Support Center